Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
Molecules
2018 Dec 15;2312:. doi: 10.3390/molecules23123334.
Show Gene links
Show Anatomy links
Looking at Marine-Derived Bioactive Molecules as Upcoming Anti-Diabetic Agents: A Special Emphasis on PTP1B Inhibitors.
Ezzat SM
,
Bishbishy MHE
,
Habtemariam S
,
Salehi B
,
Sharifi-Rad M
,
Martins N
,
Sharifi-Rad J
.
???displayArticle.abstract???
Diabetes mellitus (DM) is a chronic metabolic disease with high morbimortality rates. DM has two types: type 1, which is often associated with a total destruction of pancreatic beta cells, and non-insulin-dependent or type 2 diabetes mellitus (T2DM), more closely associated with obesity and old age. The main causes of T2DM are insulin resistance and/or inadequate insulin secretion. Protein-tyrosine phosphatase 1B (PTP1B) negatively regulates insulin signaling pathways and plays an important role in T2DM, as its overexpression may induce insulin resistance. Thus, since PTP1B may be a therapeutic target for both T2DM and obesity, the search for novel and promising natural inhibitors has gained much attention. Hence, several marine organisms, including macro and microalgae, sponges, marine invertebrates, sea urchins, seaweeds, soft corals, lichens, and sea grasses, have been recently evaluated as potential drug sources. This review provides an overview of the role of PTP1B in T2DM insulin signaling and treatment, and highlights the recent findings of several compounds and extracts derived from marine organisms and their relevance as upcoming PTP1B inhibitors. In this systematic literature review, more than 60 marine-derived metabolites exhibiting PTP1B inhibitory activity are listed. Their chemical classes, structural features, relative PTP1B inhibitory potency (assessed by IC50 values), and structure⁻activity relationships (SARs) that could be drawn from the available data are discussed. The upcoming challenge in the field of marine research-metabolomics-is also addressed.
Abdul,
Health benefit of fucosterol from marine algae: a review.
2016, Pubmed
Abdul,
Health benefit of fucosterol from marine algae: a review.
2016,
Pubmed
Ahmad,
Osmotic loading of neutralizing antibodies demonstrates a role for protein-tyrosine phosphatase 1B in negative regulation of the insulin action pathway.
1995,
Pubmed
Ahmad,
Improved sensitivity to insulin in obese subjects following weight loss is accompanied by reduced protein-tyrosine phosphatases in adipose tissue.
1997,
Pubmed
Al-Lawati,
Diabetes Mellitus: A Local and Global Public Health Emergency!
2017,
Pubmed
Ali,
α-Glucosidase and Protein Tyrosine Phosphatase 1B Inhibitory Activity of Plastoquinones from Marine Brown Alga Sargassum serratifolium.
2017,
Pubmed
American Diabetes Association,
Diagnosis and classification of diabetes mellitus.
2014,
Pubmed
American Diabetes Association,
2. Classification and Diagnosis of Diabetes.
2017,
Pubmed
Andersen,
Discovery and SAR of a novel selective and orally bioavailable nonpeptide classical competitive inhibitor class of protein-tyrosine phosphatase 1B.
2002,
Pubmed
Bandyopadhyay,
Protein-tyrosine phosphatase 1B complexes with the insulin receptor in vivo and is tyrosine-phosphorylated in the presence of insulin.
1997,
Pubmed
Bence,
Neuronal PTP1B regulates body weight, adiposity and leptin action.
2006,
Pubmed
Blunt,
Marine natural products.
2009,
Pubmed
Brown-Shimer,
Molecular cloning and chromosome mapping of the human gene encoding protein phosphotyrosyl phosphatase 1B.
1990,
Pubmed
Brownlee,
Biochemistry and molecular cell biology of diabetic complications.
2001,
Pubmed
Byon,
Protein-tyrosine phosphatase-1B acts as a negative regulator of insulin signal transduction.
1998,
Pubmed
Cheng,
Attenuation of leptin action and regulation of obesity by protein tyrosine phosphatase 1B.
2002,
Pubmed
Cheng,
Coordinated action of protein tyrosine phosphatases in insulin signal transduction.
2002,
Pubmed
Cheung,
Marked impairment of protein tyrosine phosphatase 1B activity in adipose tissue of obese subjects with and without type 2 diabetes mellitus.
1999,
Pubmed
Cho,
IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045.
2018,
Pubmed
Debbab,
Bioactive compounds from marine bacteria and fungi.
2010,
Pubmed
Dubé,
Involvement of the small protein tyrosine phosphatases TC-PTP and PTP1B in signal transduction and diseases: from diabetes, obesity to cell cycle, and cancer.
2005,
Pubmed
Elchebly,
Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene.
1999,
Pubmed
Fantus,
Modulation of insulin action by vanadate: evidence of a role for phosphotyrosine phosphatase activity to alter cellular signaling.
1996,
Pubmed
Fantus,
Multifunctional actions of vanadium compounds on insulin signaling pathways: evidence for preferential enhancement of metabolic versus mitogenic effects.
1998,
Pubmed
Fouad,
Cytotoxic isomalabaricane triterpenes from the marine sponge Rhabdastrella globostellata.
2006,
Pubmed
Goldstein,
Tyrosine dephosphorylation and deactivation of insulin receptor substrate-1 by protein-tyrosine phosphatase 1B. Possible facilitation by the formation of a ternary complex with the Grb2 adaptor protein.
2000,
Pubmed
Ingebrigtsen,
Light and temperature effects on bioactivity in diatoms.
2016,
Pubmed
Jiang,
Natural products possessing protein tyrosine phosphatase 1B (PTP1B) inhibitory activity found in the last decades.
2012,
Pubmed
Jiao,
Dysidavarones A-D, new sesquiterpene quinones from the marine sponge Dysidea avara.
2012,
Pubmed
Johnson,
Protein tyrosine phosphatase 1B inhibitors for diabetes.
2002,
Pubmed
Jung,
Antidiabetic agents from medicinal plants.
2006,
Pubmed
Jung,
Kinetics and molecular docking studies of an anti-diabetic complication inhibitor fucosterol from edible brown algae Eisenia bicyclis and Ecklonia stolonifera.
2013,
Pubmed
Kenner,
Protein-tyrosine phosphatase 1B is a negative regulator of insulin- and insulin-like growth factor-I-stimulated signaling.
1996,
Pubmed
Kim,
Potent alpha-glucosidase inhibitors purified from the red alga Grateloupia elliptica.
2008,
Pubmed
Kim,
Alpha-glucosidase inhibitory activity of bromophenol purified from the red alga Polyopes lancifolia.
2010,
Pubmed
Klaman,
Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice.
2000,
Pubmed
Kurihara,
Two new bromophenols from the red alga odonthalia corymbifera.
1999,
Pubmed
Lee,
Effects of brown alga, Ecklonia cava on glucose and lipid metabolism in C57BL/KsJ-db/db mice, a model of type 2 diabetes mellitus.
2012,
Pubmed
Lee,
PTP1B inhibitory and anti-inflammatory effects of secondary metabolites isolated from the marine-derived fungus Penicillium sp. JF-55.
2013,
Pubmed
Lee,
Octaphlorethol A, a marine algae product, exhibits antidiabetic effects in type 2 diabetic mice by activating AMP-activated protein kinase and upregulating the expression of glucose transporter 4.
2016,
Pubmed
Leung,
Periodinates: a new class of protein tyrosine phosphatase inhibitors.
1999,
Pubmed
Li,
A novel sesquiterpene quinone from Hainan sponge Dysidea villosa.
2009,
Pubmed
Liang,
Cembrane diterpenoids from the soft coral Sarcophyton trocheliophorum Marenzeller as a new class of PTP1B inhibitors.
2013,
Pubmed
Liu,
Targeting inactive enzyme conformation: aryl diketoacid derivatives as a new class of PTP1B inhibitors.
2008,
Pubmed
Lund,
Mechanism of protein tyrosine phosphatase 1B-mediated inhibition of leptin signalling.
2005,
Pubmed
Maeda,
Dietary combination of fucoxanthin and fish oil attenuates the weight gain of white adipose tissue and decreases blood glucose in obese/diabetic KK-Ay mice.
2007,
Pubmed
Manikkam,
A Review of Potential Marine-derived Hypotensive and Anti-obesity Peptides.
2016,
Pubmed
Meshkani,
Polymorphisms within the protein tyrosine phosphatase 1B (PTPN1) gene promoter: functional characterization and association with type 2 diabetes and related metabolic traits.
2007,
Pubmed
Meyerovitch,
Hepatic phosphotyrosine phosphatase activity and its alterations in diabetic rats.
1989,
Pubmed
Meyerovitch,
Oral administration of vanadate normalizes blood glucose levels in streptozotocin-treated rats. Characterization and mode of action.
1987,
Pubmed
Moon,
Protein tyrosine phosphatase 1B and α-glucosidase inhibitory Phlorotannins from edible brown algae, Ecklonia stolonifera and Eisenia bicyclis.
2011,
Pubmed
Myers,
TYK2 and JAK2 are substrates of protein-tyrosine phosphatase 1B.
2001,
Pubmed
Okada,
A new phloroglucinol derivative from the brown alga Eisenia bicyclis: potential for the effective treatment of diabetic complications.
2004,
Pubmed
Peng,
Fucoxanthin, a marine carotenoid present in brown seaweeds and diatoms: metabolism and bioactivities relevant to human health.
2011,
Pubmed
Piao,
New hippolide derivatives with protein tyrosine phosphatase 1B inhibitory activity from the marine sponge Hippospongia lachne.
2014,
Pubmed
Pontiroli,
Type 2 diabetes mellitus is becoming the most common type of diabetes in school children.
2004,
Pubmed
Qin,
Highly brominated metabolites from marine red alga Laurencia similis inhibit protein tyrosine phosphatase 1B.
2010,
Pubmed
Ruocco,
Polysaccharides from the Marine Environment with Pharmacological, Cosmeceutical and Nutraceutical Potential.
2016,
Pubmed
Saleh,
Recent Research in Antihypertensive Activity of Food Protein-derived Hydrolyzates and Peptides.
2016,
Pubmed
Scheen,
Troglitazone: antihyperglycemic activity and potential role in the treatment of type 2 diabetes.
1999,
Pubmed
Seo,
Isolation of the protein tyrosine phosphatase 1B inhibitory metabolite from the marine-derived fungus Cosmospora sp. SF-5060.
2009,
Pubmed
Shi,
[PTP1B inhibitory activities of bromophenol derivatives from algae].
2008,
Pubmed
Shi,
Bromophenols as inhibitors of protein tyrosine phosphatase 1B with antidiabetic properties.
2012,
Pubmed
Shi,
HPN, a synthetic analogue of bromophenol from red alga Rhodomela confervoides: synthesis and anti-diabetic effects in C57BL/KsJ-db/db mice.
2013,
Pubmed
Shoeib,
In-vitro cytotoxic activities of the major bromophenols of the red alga Polysiphonia lanosa and some novel synthetic isomers.
2004,
Pubmed
Sohn,
PTP1B inhibitory secondary metabolites from marine-derived fungal strains Penicillium spp. and Eurotium sp.
2013,
Pubmed
Suzen,
Recent studies of aldose reductase enzyme inhibition for diabetic complications.
2003,
Pubmed
Thilagam,
α-Glucosidase and α-amylase inhibitory activity of Senna surattensis.
2013,
Pubmed
Wang,
Structures and aldose reductase inhibitory effects of bromophenols from the red alga Symphyocladia latiuscula.
2005,
Pubmed
Wilson,
Structure-based optimization of protein tyrosine phosphatase 1B inhibitors: from the active site to the second phosphotyrosine binding site.
2007,
Pubmed
Wu,
Protein-tyrosine phosphatase activity in human adipocytes is strongly correlated with insulin-stimulated glucose uptake and is a target of insulin-induced oxidative inhibition.
2003,
Pubmed
Xiao,
Dietary polyphenols and type 2 diabetes: current insights and future perspectives.
2015,
Pubmed
Yamazaki,
A polybromodiphenyl ether from an Indonesian marine sponge Lamellodysidea herbacea and its chemical derivatives inhibit protein tyrosine phosphatase 1B, an important target for diabetes treatment.
2013,
Pubmed
Yamazaki,
Euryspongins A-C, three new unique sesquiterpenes from a marine sponge Euryspongia sp.
2013,
Pubmed
Zabolotny,
PTP1B regulates leptin signal transduction in vivo.
2002,
Pubmed
Zhang,
PTP1B inhibitors as potential therapeutics in the treatment of type 2 diabetes and obesity.
2003,
Pubmed
Zhang,
PTP1B as a drug target: recent developments in PTP1B inhibitor discovery.
2007,
Pubmed
Zhang,
A sesquiterpene quinone, dysidine, from the sponge Dysidea villosa, activates the insulin pathway through inhibition of PTPases.
2009,
Pubmed
Zhao,
Isoxazole carboxylic acids as protein tyrosine phosphatase 1B (PTP1B) inhibitors.
2004,
Pubmed
Zhou,
Bioactivities of six sterols isolated from marine invertebrates.
2014,
Pubmed
,
Echinobase
Zinker,
PTP1B antisense oligonucleotide lowers PTP1B protein, normalizes blood glucose, and improves insulin sensitivity in diabetic mice.
2002,
Pubmed
